Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Solifenacin Add-on for Residual OAB Symptoms
NCT00884104Phase 4Completed
- Start
- Mar 2009
- Primary completion
- Dec 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of solifenacin in overactive bladder (OAB). Started Mar 2009; status: completed.
02
Drugs
solifenacin
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT00884104.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00884104.